VRTX
Vertex Pharmaceuticals Incorporated
- Total liabilities, 2025
- $7.0B
- YoY, 2025
- +13.9%
- 5-year CAGR
- +17.9%
- 10-year CAGR
- +17.4%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $7.0B | +13.9% |
| 2024 | $6.1B | +18.9% |
| 2023 | $5.1B | +21.5% |
| 2022 | $4.2B | +27.2% |
| 2021 | $3.3B | +8.7% |
| 2020 | $3.1B | +37.2% |
| 2019 | $2.2B | +23.3% |
| 2018 | $1.8B | +20.4% |
| 2017 | $1.5B | −3.5% |
| 2016 | $1.6B | +10.9% |
| 2015 | $1.4B | +13.4% |
| 2014 | $1.2B | +28.7% |
| 2013 | $963M | −36.9% |
| 2012 | $1.5B | +23.1% |
| 2011 | $1.2B | +1.4% |
| 2010 | $1.2B | +42.2% |
| 2009 | $859M | — |